Table 3. Univariate analysis of histological and molecular subgroups for OS and EFS in medulloblastoma patients (n = 173).

Factors	No. of cases	5-year OS(%)	p-value	5-year EFS(%)	p-value
Histological subgroups
CMB	119	51.7	0.187	46.7	0.643
DMB	45	61.0		45.7
AMB	9	18.5		18.5
Molecular subgroups
SHH	40	50.4	0.182	40.9	0.277
WNT	37	69.2		59.2
Non-SHH/WNT	96	45.9		41.0
Molecular subgroupsa
WNT	30	83.3	0.028	78.6	0.081
Other	118	54.9		44.6

CMB = Classic medulloblastoma, DMB = Desmoplastic/nodular medulloblastoma, AMB = Large-cell/anaplastic medulloblastoma, SHH = SHH pathway medulloblastoma, WNT = WNT pathway medulloblastoma, Non-SHH/WNT =  Non-SHH/WNT pathway medulloblastoma.

^athose patients who did not receive any adjuvant therapies after primary resection were excluded.